Thursday, September 28, 2023
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Merck’s anti-PD-1 therapy KEYTRUDA(pembrolizumab) for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

admin - 0
Latest Pharma-News

Due to Potential Battery Failure Getinge’s Maquet / Datascope Recalls Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i Intra-Aortic Balloon Pumps (IABP)

admin - 0
Latest Pharma-News

First-in-human clinical trial to evaluate CAR-Treg Cell Therapy TX200 for Kidney Transplantation approved for Phase 1/2 Clinical Trial

admin - 0
Latest Pharma-News

KarXT enrolled in Phase II clinical trial for the treatment of acute psychosis in schizophrenia patients

admin - 0
Latest Pharma-News

TWILIGHT trial showed that Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding compared to dual antiplatelet therapy (DAPT) in patients with non-ST...

admin - 0
Latest Pharma-News

Novartis Phase III PARAGON-HF study: Substantial reductions in heart failure with preserved ejection fraction with Entresto

admin - 0
Latest Pharma-News

Cardiff University’s scientist awarded the funding of £373k to diagnose pancreatic cancer at an earlier stage

admin - 0
Latest Pharma-News

SurVaxM: A novel anti-cancer immunotherapy for the treatment of glioblastoma brain cancers

admin - 0
Latest Pharma-News

Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors

admin - 0
Latest Pharma-News

Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression

admin - 0
Latest Pharma-News

New Novartis medicine Adakveo® (crizanlizumab) approved by FDA for the treatment of individuals living with sickle cell disease

admin - 0
Latest Pharma-News

BMS and Pfizer to start a new randamized controlled trial accessing the impact of atrial fibrillation screening on health outcomes in older individuals

admin - 0
1...142143144Page 143 of 144
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved